Canada Peptide Therapeutics Market Size & Outlook

The peptide therapeutics market in Canada is expected to reach a projected revenue of US$ 9,217.3 million by 2030. A compound annual growth rate of 15.1% is expected of Canada peptide therapeutics market from 2024 to 2030.
Revenue, 2023 (US$M)
$3,445.5
Forecast, 2030 (US$M)
$9,217.3
CAGR, 2024 - 2030
15.1%
Report Coverage
Canada

Canada peptide therapeutics market highlights

  • The Canada peptide therapeutics market generated a revenue of USD 3,445.5 million in 2023 and is expected to reach USD 9,217.3 million by 2030.
  • The Canada market is expected to grow at a CAGR of 15.1% from 2024 to 2030.
  • In terms of segment, metabolic disorders was the largest revenue generating application in 2023.
  • Metabolic disorders is the most lucrative application segment registering the fastest growth during the forecast period.

Peptide therapeutics market data book summary

Market revenue in 2023USD 3,445.5 million
Market revenue in 2030USD 9,217.3 million
Growth rate15.1% (CAGR from 2023 to 2030)
Largest segmentMetabolic disorders
Fastest growing segmentMetabolic disorders
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCancer, Metabolic disorders, Cardiovascular disorders, Respiratory disorders, Gastrointestinal disorders, Infectious disease, Pain, Dermatological disorders, Neurological disorders, Renal disorders
Key market players worldwideEli Lilly and Co, Pfizer Inc, Amgen Inc, Takeda Pharmaceutical Co Ltd, AstraZeneca PLC, Teva Pharmaceutical Industries Ltd, Sanofi SA, Roche Holding AG, Novartis AG ADR, Novo Nordisk A/S ADR, GlaxoSmithKline, Ironwood Pharmaceuticals Inc Class A, Ipsen SA, Radius Health

Other key industry trends

  • In terms of revenue, Canada accounted for 3.7% of the global peptide therapeutics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. peptide therapeutics market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 160,325.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Peptide Therapeutics Market Scope

Peptide therapeutics market segmentation & scope
Cancer
Metabolic disorders
Cardiovascular disorders
Respiratory disorders
Gastrointestinal disorders
Infectious disease
Pain
Dermatological disorders
Neurological disorders
Renal disorders
Others
Generic
Innovative
Inhouse
Outsourced
Parenteral Route
Oral Route
Pulmonary
Mucosal
Others
Recombinant DNA Technology
Solid-Phase Peptide Synthesis (SPPS)
Hybrid
Liquid-Phase Peptide Synthesis (LPPS)
Others
Inhouse
Outsourced

Peptide Therapeutics Market Companies

Name Profile # Employees HQ Website

Canada peptide therapeutics market size, by application, 2018-2030 (US$M)

Canada Peptide Therapeutics Market Outlook Share, 2023 & 2030 (US$M)

Canada peptide therapeutics market size, by application, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more